Ovid Therapeutics Inc.

3.36 USD
+0.01 (+0.30%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Ovid Therapeutics Inc. stock is up 5.99% since 30 days ago. The next earnings date is Mar 11, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 28.57% of the previous 6 December’s closed higher than November.

About Ovid Therapeutics Inc.

Ovid Therapeutics Inc. develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome. OV329, a GABA aminotransferase inhibitor, and OV350, a small molecule for treating epilepsies.